Sign in

CIK 0001636282 · Large accelerated filer

Spyre Therapeutics, Inc.

Sign in to watch
Ticker
SYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464312787
Phone
6176515940
Business address
221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
Aeglea BioTherapeutics, Inc.
  1. S-1/A Offering Registration Statement
  2. CORRESP Other Correspondence Between Filers and SEC Staff
  3. 4 Insider Changes in Ownership
  4. 4 Insider Changes in Ownership
  5. 4 Insider Changes in Ownership
  6. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  7. UPLOAD Other SEC-generated Letter
  8. 8-K Event Delisting notice
  9. SC 13D/A Stake Beneficial Ownership Report
  10. 4 Insider Changes in Ownership
  11. D Other Notice of Sales of Unregistered Securities
  12. 4 Insider Changes in Ownership
  13. S-8 Other Securities Offered to Employees in Benefit Plans
  14. S-1 Offering Registration Statement
  15. SC 13G Stake Amended Statement of Ownership
  16. 4 Insider Changes in Ownership
  17. SC 13D/A Stake Beneficial Ownership Report
  18. 4/A Insider Changes in Ownership
  19. 424B3 Offering Prospectus
  20. 3/A Insider 3/A

Page 14 of 42 · 823 filings